Home / KEEP BUT DO NOT DISPLAY (page 27)

KEEP BUT DO NOT DISPLAY

Why South Asians Have a Higher Risk for Diabetes

Data on U.S. residents showed those of South Asian descent had a diabetes prevalence of 23%, compared with 6% in whites, 18% in blacks, 17% in Latinos and 13% in Chinese-Americans. However, traditional risk factors did not appear to explain the heightened prevalence among South Asians, researchers said. "The study …

Read More »

A Breakthrough in Detecting Brown Fat

Researchers in the UK have detected energy-burning "brown fat" through MRI for the first time according to a new published study. Thomas Barber, MBBS, DPhil, from the department of metabolic and vascular health at Warwick Medical School, said that, "The MRI allows us to distinguish between the brown fat, and …

Read More »

Actos Generic Available Shortly from Lupin

Actos Generic Available Shortly from Lupin – Lupin has announced that it received final approval from the FDA for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths. The product is the generic version of Actos tablets from Takeda Pharmaceuticals. Albiglutide, Weekly Injectable GLP-1 Drug, Receives FDA Approval –  (See this week’s Item #6.) 

Read More »

Diabetes Expenses Have Decreased but Still High

Out-of-pocket expenses for diabetes treatment have gone down for many U.S. patients over the past decade, according to a new study. But nearly a quarter of people with diabetes still face high expenses. In particular, (out-of-pocket) expenses declined in the people with public insurance and in people with low income …

Read More »

Obesity Blamed for Rise in Diabetes

 An ‘alarming’ rise in obesity has contributed to a dramatic increase in the prevalence of diabetes in the U.S, according to a new study. Researchers examined the prevalence of diabetes, prediabetes, and glycemic control in 43,439 adults in the NHANES study from 1988 to 1994 and 1999 to 2010. The …

Read More »

In Two Decades, Diabetes Doubled

The authors of a new study found that the rise in diabetes from 5.5% to 9.3% of the U.S. population over the last 20 years paralleled the growing rate of obesity in America. Better screening tools such as the HbA1c diagnostic test have also helped physicians identify more diabetes cases, …

Read More »

Lifetime Cost of Childhood Obesity Is $19,000 Per Child

Childhood obesity carries an estimated price tag of $19,000 per child in lifetime direct medical costs, when compared to the medical costs to those of a normal weight child. When the estimate was applied for all 10-year-olds in the U.S. who are obese, the medical costs over a lifetime for …

Read More »

Resveratrol’s Potential in Glucose Control

Resveratrol was associated with significant improvements in fasting glucose, insulin and A1C levels in patients with diabetes, according to a meta-analysis. However, researchers did not observe the same benefits in those who did not have diabetes. From eleven studies with a total of 388 subjects researchers concluded that resveratrol significantly …

Read More »

Decrease in Carbohydrate Consumption

Consumption of carbohydrate-rich foods has fallen 5% during the last four years while protein-rich food consumption has risen 7% and will continue. Unlike the Atkins diet fad of the mid-2000s, this demand shift appears to have staying power as consumers holistically try to increase the ‘good fats’ in their diet …

Read More »